title: Analysis of human papillomavirus type 16 (HPV16) DNA load and physical state for identification of HPV16-infected women with high-grade lesions or cervical carcinoma.
abstract: Integration of human papillomavirus (HPV) DNA into the host cell genome is a frequent event in cervical carcinogenesis, even though this phenomenon does not seem to be mandatory for cervical cancer development. Our objective was to describe the load and physical state of HPV type 16 (HPV16) DNA in a series of cervical samples representative of the natural history of cervical cancer. We used a combination of three real-time PCR assays targeting E6, E2, and albumin genes to calculate HPV16 load (E6 and albumin) and the E2/E6 ratio as a surrogate of integration. This method was applied to 173 HPV16-positive cervical samples. Results show that viral load increases with the lesion grade (from 102 HPV16 DNA copies per 10(3) cells in normal samples up to 56,354 copies per 10(3) cells in cancers), while E2/E6 ratio decreases (from 1 in normal samples down to 0.36 in cancers). We propose that, according to this technique, an HPV16 viral load of higher than 22,000 copies/10(3) cells or an E2/E6 ratio of lower than 0.50 allows the identification of women with prevalent high-grade lesions or worse with a high specificity. In conclusion, both viral load and E2/E6 ratio, used in combination with an appropriate cutoff value, are suitable to screen women with prevalent cervical intraepithelial neoplasia grade 2 or 3 or cancer. Therefore, these assays would be useful in addition to routine HPV testing to more accurately identify women with (pre)cancerous lesions.
authors.affiliation: Laboratoire de Biologie Cellulaire et Moléculaire, IFR 133, Université de Franche-Comté, Centre Hospitalier Universitaire, Boulevard A. Fleming, 25030 Besançon cedex, France. jean_luc.pretet@univ-fcomte.fr
authors.forename: Maëlle
authors.initials: M
authors.lastname: Saunier
authors.forename: Sylvain
authors.initials: S
authors.lastname: Monnier-Benoit
authors.forename: Frédéric
authors.initials: F
authors.lastname: Mauny
authors.forename: Véronique
authors.initials: V
authors.lastname: Dalstein
authors.forename: Jenny
authors.initials: J
authors.lastname: Briolat
authors.forename: Didier
authors.initials: D
authors.lastname: Riethmuller
authors.forename: Bernadette
authors.initials: B
authors.lastname: Kantelip
authors.forename: Elisabeth
authors.initials: E
authors.lastname: Schwarz
authors.forename: Christiane
authors.initials: C
authors.lastname: Mougin
authors.forename: Jean-Luc
authors.initials: JL
authors.lastname: Prétet
mesh_terms: D017931:DNA Primers / Q000235:genetics; D004279:DNA, Viral / Q000235:genetics / Q000302:isolation & purification*; D004268:DNA-Binding Proteins / Q000235:genetics; D005260:Female; D052162:Human papillomavirus 16 / Q000235:genetics / Q000302:isolation & purification*; D006801:Humans; D009856:Oncogene Proteins, Viral / Q000235:genetics; D030361:Papillomavirus Infections / Q000473:pathology* / Q000821:virology*; D016133:Polymerase Chain Reaction / Q000379:methods; D012097:Repressor Proteins / Q000235:genetics; D013223:Statistics as Topic; D002583:Uterine Cervical Neoplasms / Q000175:diagnosis / Q000473:pathology* / Q000821:virology*
chemical_list: D017931:DNA Primers; D004279:DNA, Viral; D004268:DNA-Binding Proteins; C054855:E2 protein, Human papillomavirus type 16; C068651:E6 protein, Human papillomavirus type 16; D009856:Oncogene Proteins, Viral; D012097:Repressor Proteins
references.citation: J Clin Microbiol. 2002 Mar;40(3):863-7
references.pmid: 11880406
references.citation: Int J Cancer. 2008 Jan 15;122(2):424-7
references.pmid: 17893883
references.citation: J Clin Virol. 2005 Mar;32 Suppl 1:S7-15
references.pmid: 15753007
references.citation: Am Fam Physician. 1995 Feb 1;51(2):434-40, 443-4
references.pmid: 7840040
references.citation: Virology. 2004 Jun 20;324(1):17-27
references.pmid: 15183049
references.citation: Lancet. 2004 Nov 6-12;364(9446):1678-83
references.pmid: 15530628
references.citation: N Engl J Med. 2003 Feb 6;348(6):518-27
references.pmid: 12571259
references.citation: Cancer Res. 2000 Nov 1;60(21):6027-32
references.pmid: 11085523
references.citation: Cancer Epidemiol Biomarkers Prev. 2005 Nov;14(11 Pt 1):2544-9
references.pmid: 16284376
references.citation: J Natl Cancer Inst. 1995 Sep 20;87(18):1365-71
references.pmid: 7658497
references.citation: J Gen Virol. 1999 Jul;80 ( Pt 7):1725-1733
references.pmid: 10423141
references.citation: J Clin Microbiol. 2003 Feb;41(2):608-12
references.pmid: 12574254
references.citation: J Clin Virol. 2006 Mar;35(3):270-7
references.pmid: 16214397
references.citation: Gynecol Oncol. 2007 Sep;106(3):549-57
references.pmid: 17568661
references.citation: Int J Cancer. 2008 Jan 15;122(2):428-32
references.pmid: 17893882
references.citation: Int J Gynecol Pathol. 1993 Apr;12(2):186-92
references.pmid: 8463044
references.citation: Int J Cancer. 2002 Apr 1;98(4):590-5
references.pmid: 11920620
references.citation: Int J Cancer. 2004 Aug 20;111(2):278-85
references.pmid: 15197783
references.citation: J Virol. 1987 Apr;61(4):962-71
references.pmid: 3029430
references.citation: Vaccine. 2006 Aug 31;24 Suppl 3:S3/26-34
references.pmid: 16950015
references.citation: Br J Cancer. 2005 Jun 20;92(12):2195-200
references.pmid: 15942630
references.citation: Int J Cancer. 2007 Nov 15;121(10):2198-204
references.pmid: 17657742
references.citation: Int J Cancer. 2003 Sep 1;106(3):396-403
references.pmid: 12845680
references.citation: Clin Infect Dis. 2005 Feb 1;40(3):451-7
references.pmid: 15668870
references.citation: Cancer Res. 2006 Oct 15;66(20):10112-9
references.pmid: 17047075
references.citation: Proc Natl Acad Sci U S A. 1992 Apr 1;89(7):3159-63
references.pmid: 1313584
references.citation: J Natl Cancer Inst. 2005 Jul 20;97(14):1072-9
references.pmid: 16030305
references.citation: J Clin Microbiol. 2002 Mar;40(3):886-91
references.pmid: 11880410
references.citation: Cancer Epidemiol Biomarkers Prev. 2003 Oct;12(10):1038-44
references.pmid: 14578140
references.citation: Lancet. 2001 Jun 9;357(9271):1831-6
references.pmid: 11410191
references.citation: J Clin Pathol. 2006 May;59(5):513-7
references.pmid: 16484445
references.citation: J Clin Microbiol. 2006 May;44(5):1755-62
references.pmid: 16672403
references.citation: Int J Cancer. 2007 Dec 15;121(12):2787-93
references.pmid: 17722112
references.citation: J Clin Microbiol. 2007 Mar;45(3):897-901
references.pmid: 17229868
references.citation: Diagn Mol Pathol. 2005 Jun;14(2):103-8
references.pmid: 15905694
references.citation: J Med Virol. 2006 Aug;78(8):1131-40
references.pmid: 16789021
references.citation: Gynecol Oncol. 2004 Mar;92(3):873-80
references.pmid: 14984955
references.citation: J Clin Virol. 2001 May;21(2):129-34
references.pmid: 11378493
references.citation: J Virol. 1989 Mar;63(3):1404-7
references.pmid: 2536841
references.citation: Int J Gynecol Pathol. 1998 Apr;17(2):146-53
references.pmid: 9553812
references.citation: J Clin Virol. 2004 Oct;31(2):140-7
references.pmid: 15364271
references.citation: J Clin Pathol. 2001 May;54(5):377-80
references.pmid: 11328837
references.citation: J Clin Pathol. 2003 Jul;56(7):532-6
references.pmid: 12835300
references.citation: Obstet Gynecol. 1998 Oct;92(4 Pt 2):727-35
references.pmid: 9764690
references.citation: Eur J Cancer. 2002 Jan;38(1):99-166
references.pmid: 11750846
references.citation: Int J Cancer. 2007 Aug 1;121(3):621-32
references.pmid: 17405118
references.citation: N Engl J Med. 1999 Nov 25;341(22):1633-8
references.pmid: 10572150
references.citation: Lancet Oncol. 2001 Sep;2(9):533-43
references.pmid: 11905707
references.citation: J Pathol. 1999 Sep;189(1):12-9
references.pmid: 10451482
references.citation: Clin Chem. 1999 Jul;45(7):982-6
references.pmid: 10388473
references.citation: J Virol. 2004 Nov;78(21):11451-60
references.pmid: 15479788
references.citation: Lancet. 2000 Jun 24;355(9222):2189-93
references.pmid: 10881891
references.citation: Gynecol Obstet Fertil. 2006 Jan;34(1):44-8
references.pmid: 16406731
references.citation: J Infect Dis. 1999 Nov;180(5):1415-23
references.pmid: 10515798
references.citation: J Natl Cancer Inst. 1995 Jun 7;87(11):796-802
references.pmid: 7791229